HomeCompareCLNFF vs JNJ

CLNFF vs JNJ: Dividend Comparison 2026

CLNFF yields 1.61% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLNFF wins by $2.2K in total portfolio value
10 years
CLNFF
CLNFF
● Live price
1.61%
Share price
$50.39
Annual div
$0.81
5Y div CAGR
1.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.3K
Annual income
$217.94
Full CLNFF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CLNFF vs JNJ

📍 CLNFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLNFFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLNFF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLNFF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLNFF
Annual income on $10K today (after 15% tax)
$136.96/yr
After 10yr DRIP, annual income (after tax)
$185.25/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $518.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLNFF + JNJ for your $10,000?

CLNFF: 50%JNJ: 50%
100% JNJ50/50100% CLNFF
Portfolio after 10yr
$21.1K
Annual income
$522.86/yr
Blended yield
2.47%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CLNFF
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
2.8
Piotroski
8/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLNFF buys
0
JNJ buys
0
No recent congressional trades found for CLNFF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLNFFJNJ
Forward yield1.61%3.36%
Annual dividend / share$0.81$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR1.9%5.8%
Portfolio after 10y$22.3K$20.0K
Annual income after 10y$217.94$827.78
Total dividends collected$1.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: CLNFF vs JNJ ($10,000, DRIP)

YearCLNFF PortfolioCLNFF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,864$164.20$10,676$355.77+$188.00CLNFF
2$11,795$169.88$11,407$389.39+$388.00CLNFF
3$12,796$175.64$12,198$426.53+$598.00CLNFF
4$13,873$181.47$13,056$467.62+$817.00CLNFF
5$15,031$187.37$13,987$513.12+$1.0KCLNFF
6$16,277$193.34$14,998$563.56+$1.3KCLNFF
7$17,616$199.38$16,098$619.52+$1.5KCLNFF
8$19,054$205.49$17,295$681.69+$1.8KCLNFF
9$20,600$211.68$18,599$750.82+$2.0KCLNFF
10$22,260$217.94$20,022$827.78+$2.2KCLNFF

CLNFF vs JNJ: Complete Analysis 2026

CLNFFStock

Calian Group Ltd. provides business services and solutions in the areas of health, defense, security, aerospace, engineering, AgTech, and information technology (IT) in Canada, the United States, and Europe. The company's Advanced Technologies segment offers developed products and engineering solutions for the space, communications, nuclear, agriculture, defense, automotive, and government sectors; software and product development, custom manufacturing, full life-cycle support, studies, requirements analysis, project management, multi-discipline engineered system solutions, and training services; communication systems and products for terrestrial and satellite networks; satellite gateways comprising aperture radio frequency antennas, and telemetry tracking and control, as well as software solutions for managing and monitoring networks; engineering and technical services for propulsion, electrical and electronic systems, computer and nuclear systems, naval architecture, and aerospace; and nuclear services to develop waste management and decommissioning solutions. Its Health segment offers primary care and occupational health services; and clinic management, healthcare practitioner support, and psychological assessment services. The company's Learning segment provides training services and solutions; and consulting services in emergency management, training, and advanced training technologies, as well as Calian MaestroEDE, a tool for collective training exercises for military customers; and Calian ResponseReady, an online platform and simulation tool for emergency management training exercise delivery and evaluation. Its IT segment provides cloud migration, IT development, SAP consulting, and cyber security solutions, as well as IT support services. The company was formerly known as Calian Technologies Ltd. and changed its name to Calian Group Ltd. in April 2016. The company was incorporated in 1982 and is headquartered in Ottawa, Canada.

Full CLNFF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CLNFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLNFF vs SCHDCLNFF vs JEPICLNFF vs OCLNFF vs KOCLNFF vs MAINCLNFF vs ABBVCLNFF vs MRKCLNFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.